J. W. Coons Advisors LLC Has $5.34 Million Holdings in Johnson & Johnson (NYSE:JNJ)

J. W. Coons Advisors LLC grew its position in shares of Johnson & Johnson (NYSE:JNJ – Get Rating) by 2.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 30,212 shares of the company’s stock after acquiring an additional 739 shares during the quarter. Johnson & Johnson accounts for approximately 1.6% of J. W. Coons Advisors LLC’s portfolio, making the stock its 7th largest holding. J. W. Coons Advisors LLC’s holdings in Johnson & Johnson were worth $5,337,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Glassy Mountain Advisors Inc. purchased a new stake in Johnson & Johnson during the fourth quarter worth about $35,000. Retirement Financial Solutions LLC purchased a new position in Johnson & Johnson in the fourth quarter valued at approximately $40,000. TD Capital Management LLC bought a new position in Johnson & Johnson during the third quarter valued at $48,000. VitalStone Financial LLC purchased a new stake in Johnson & Johnson in the fourth quarter worth $52,000. Finally, Iron Horse Wealth Management LLC raised its stake in shares of Johnson & Johnson by 112.8% in the fourth quarter. Iron Horse Wealth Management LLC now owns 300 shares of the company’s stock valued at $53,000 after buying an additional 159 shares during the period. Institutional investors own 67.94% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on JNJ shares. Atlantic Securities decreased their price objective on Johnson & Johnson from $168.00 to $167.00 and set a “neutral” rating for the company in a report on Wednesday, April 19th. Piper Sandler lowered their price target on shares of Johnson & Johnson from $55.00 to $52.00 in a research report on Monday, February 6th. Raymond James reduced their price objective on shares of Johnson & Johnson from $185.00 to $181.00 and set an “outperform” rating for the company in a research note on Wednesday, April 19th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $215.00 price target on shares of Johnson & Johnson in a report on Wednesday, February 1st. Finally, Guggenheim initiated coverage on Johnson & Johnson in a research note on Tuesday, February 28th. They set a “neutral” rating and a $161.00 price objective on the stock. Seven research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $173.00.

Johnson & Johnson Price Performance

Want More Great Investing Ideas?

Shares of NYSE:JNJ opened at $161.65 on Thursday. Johnson & Johnson has a one year low of $150.11 and a one year high of $183.35. The company’s fifty day moving average price is $158.80 and its 200-day moving average price is $166.87. The firm has a market capitalization of $420.08 billion, a price-to-earnings ratio of 33.82, a PEG ratio of 2.77 and a beta of 0.53. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.07 and a quick ratio of 0.85.

Johnson & Johnson (NYSE:JNJ – Get Rating) last issued its earnings results on Tuesday, April 18th. The company reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.51 by $0.17. The business had revenue of $24.75 billion during the quarter, compared to analyst estimates of $23.61 billion. Johnson & Johnson had a return on equity of 36.13% and a net margin of 13.22%. Johnson & Johnson’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.67 earnings per share. On average, equities research analysts anticipate that Johnson & Johnson will post 10.66 earnings per share for the current fiscal year.

Johnson & Johnson Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 6th. Stockholders of record on Tuesday, May 23rd will be paid a dividend of $1.19 per share. This is a boost from Johnson & Johnson’s previous quarterly dividend of $1.13. This represents a $4.76 dividend on an annualized basis and a dividend yield of 2.94%. The ex-dividend date of this dividend is Monday, May 22nd. Johnson & Johnson’s dividend payout ratio (DPR) is 94.56%.

Insider Transactions at Johnson & Johnson

In other Johnson & Johnson news, insider James D. Swanson sold 1,062 shares of Johnson & Johnson stock in a transaction that occurred on Monday, March 6th. The stock was sold at an average price of $154.66, for a total value of $164,248.92. Following the transaction, the insider now directly owns 9,215 shares of the company’s stock, valued at approximately $1,425,191.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.20% of the company’s stock.

Johnson & Johnson Profile

(Get Rating)

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets.